Literature DB >> 29198703

Impaired autophagy promotes bile acid-induced hepatic injury and accumulation of ubiquitinated proteins.

Soojin Kim1, Seung Yun Han2, Kwang Sik Yu2, Daewon Han1, Hyo-Ju Ahn1, Jae-Eun Jo1, Jin-Hoi Kim3, Jongdae Shin1, Hwan-Woo Park4.   

Abstract

Chronic exposure to hydrophobic bile acids such as chenodeoxycholic acid (CDCA) and cholic acid (CA) in the liver during cholestasis causes hepatotoxicity and inflammatory response. However, the detailed mechanisms regarding the role of autophagy in cholestatic hepatotoxicity remain largely unknown. Here we determined autophagic clearance in livers of bile duct-ligated mice, in which bile acids accumulate, and in human hepatoma HepG2 cells treated with CDCA and CA. The accumulation of bile acids caused defective autophagic clearance, shown by the accumulation of insoluble p62 and ubiquitinated proteins and cell death accompanied by caspase-3 processing. Hepatocytes exposed to bile acids also showed the accumulation of autophagosomes via suppressed autophagy flux. Treatment of CDCA markedly suppressed Beclin-1 expression, which exhibits a higher cytotoxicity than CA. Moreover, pharmacological or genetic inhibition of autophagy enhanced bile acid-induced cell death. Finally, in vivo, bile duct ligation led to aberrant accumulation of p62 and ubiquitinated proteins in the liver. Our data demonstrate that inhibited autophagy is an essential component of liver injury during cholestasis.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autophagosome; Autophagy; Bile acid; Bile duct ligation; Chenodeoxycholic acid; Cholic acid

Mesh:

Substances:

Year:  2017        PMID: 29198703     DOI: 10.1016/j.bbrc.2017.11.202

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  Cholesterol and bile acid-mediated regulation of autophagy in fatty liver diseases and atherosclerosis.

Authors:  Yifeng Wang; Wen-Xing Ding; Tiangang Li
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-04-10       Impact factor: 4.698

2.  Bile Acid Toxicity and Protein Kinases.

Authors:  Atilla Engin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Cholestatic liver disease results increased production of reactive aldehydes and an atypical periportal hepatic antioxidant response.

Authors:  Colin T Shearn; Blair Fennimore; David J Orlicky; Yue R Gao; Laura M Saba; Kayla D Battista; Stefanos Aivazidis; Mohammed Assiri; Peter S Harris; Cole Michel; Gary F Merrill; Edward E Schmidt; Sean P Colgan; Dennis R Petersen
Journal:  Free Radic Biol Med       Date:  2019-08-01       Impact factor: 7.376

4.  Upregulation of IGF2R evades lysosomal dysfunction-induced apoptosis of cervical cancer cells via transport of cathepsins.

Authors:  Takashi Takeda; Masayuki Komatsu; Fumiko Chiwaki; Rie Komatsuzaki; Kanako Nakamura; Kosuke Tsuji; Yusuke Kobayashi; Eiichiro Tominaga; Masaya Ono; Kouji Banno; Daisuke Aoki; Hiroki Sasaki
Journal:  Cell Death Dis       Date:  2019-11-20       Impact factor: 8.469

5.  Amitriptyline interferes with autophagy-mediated clearance of protein aggregates via inhibiting autophagosome maturation in neuronal cells.

Authors:  Yoonjung Kwon; Yeojin Bang; Soung-Hee Moon; Aeri Kim; Hyun Jin Choi
Journal:  Cell Death Dis       Date:  2020-10-17       Impact factor: 8.469

Review 6.  Autophagy in liver diseases.

Authors:  Elias Kouroumalis; Argryro Voumvouraki; Aikaterini Augoustaki; Dimitrios N Samonakis
Journal:  World J Hepatol       Date:  2021-01-27

7.  Sestrin2 protects against cholestatic liver injury by inhibiting endoplasmic reticulum stress and NLRP3 inflammasome-mediated pyroptosis.

Authors:  Daewon Han; Haeil Kim; Soojin Kim; Qui Anh Le; Seung Yun Han; Jeongyun Bae; Hye Won Shin; Hyun-Goo Kang; Kyung Ho Han; Jongdae Shin; Hwan-Woo Park
Journal:  Exp Mol Med       Date:  2022-03-08       Impact factor: 12.153

Review 8.  Autophagy in liver diseases: A review.

Authors:  Hui Qian; Xiaojuan Chao; Jessica Williams; Sam Fulte; Tiangang Li; Ling Yang; Wen-Xing Ding
Journal:  Mol Aspects Med       Date:  2021-06-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.